The role of magnetic resonance in the assessment of multiple sclerosis

Journal of the Neurological Sciences

Volumn 172, Issue SUPPL. 1, 2000, Pages S3-

  Rovaris, Marco ^a   Filippi, Massimo ^a  

^a Scientific Institute Ospedale   (Italy)

Author keywords

Diffusion weighted imaging; Magnetic resonance imaging; Magnetic resonance spectroscopy; Magnetization transfer imaging; Multiple sclerosis

Indexed keywords

MYELIN; WATER;

BRAIN TISSUE; DEMYELINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE COURSE; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW;

EID: 0033992424     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00270-1     Document Type: Article

References (118)

1. Miller D.H., Grossman R.I., Reingold S.C., McFarland H.F. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain. 121:1998;3-24.
2. Bastianello S., Bozzao A., Paolillo A., et al. Fast spin-echo and fast fluid-attenuated inversion recovery sequences versus conventional spin-echo for MR quantification of multiple sclerosis lesions. Am. J. Neuroradiol. 18:1997;699-704.
3. Maubon A.J., Pothin A., Ferru J.M., Berger V.M., Daures J.P., Rouanet J.P. Unselected brain 0.5 T MR imaging: comparison of lesion detection and characterization with three T2-weighted sequences. Radiology. 208:1998;671-678.
4. Rovaris M., Gawne-Cain M.L., Wang L., Miller D.H. A comparison of conventional and fast spin-echo sequences for the measurement of lesion load in multiple sclerosis using a semi-automated contour technique. Neuroradiology. 39:1997;161-165.
5. Rovaris M., Yousry T., Calori G., Fesl G., Voltz R., Filippi M. Sensitivity and reproducibility of fast-FLAIR, FSE and TGSE sequences for the assessment of brain MRI lesion load in multiple sclerosis: a preliminary study. J. Neuroimaging. 7:1997;98-102.
6. Filippi M., Horsfield M.A., Rovaris M., et al. Intraobserver and interobserver variability in schemes for estimating volume of brain lesions on MR images in multiple sclerosis. Am. J. Neuroradiol. 19:1998;239-244.
7. Gawne-Cain M.L., O'Riordan J.I., Thompson A.J., Moseley I.F., Miller D.H. Multiple sclerosis lesion detection in the brain: a comparison of fast fluid attenuated inversion recovery and conventional T2 weighted dual spin-echo. Neurology. 49:1997;364-370.
8. Gawne-Cain M.L., O'Riordan J.I., Coles A., Newell B., Thompson A.J., Miller D.H. MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid-attenuated inversion recovery (fFLAIR) and spin-echo sequences. J. Neurol. Neurosurg. Psychiatry. 64:1998;197-203.
9. Stevenson V.L., Gawne-Cain M.L., Barker G.J., Thompson A.J., Miller D.H. Imaging of the spinal cord and brain in multiple sclerosis: a comparison between fast-FLAIR and fast spin-echo. J. Neurol. 224:1997;119-124.
10. Arnold D.L., Wolinsky J.S., Matthews P.M., Falini A. The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 64:(Suppl 1):1998;S94-S101.
11. McGowan J.C., Filippi M., Campi A., Grossman R.I. Magnetisation transfer imaging: theory and application to multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 64:(Suppl 1):1998;S66-S69.
12. Horsfield M.A., Lai M., Webb S.L., et al. Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance. Magn. Reson. Med. 36:1996;393-400.
13. Yousry T.A., Berry I., Filippi M. Functional magnetic resonance imaging in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 64:(Suppl 1):1998;S85-S87.
14. Filippi M., Mastronardo G., Bastianello S., et al. A longitudinal brain MRI study comparing the sensitivities of the conventional and a newer approach for detecting active lesions in multiple sclerosis. J. Neurol. Sci. 159:1998;94-101.
15. Molyneux P.D., Tofts P.S., Fletcher A., et al. Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques. J. Neurol. Neurosurg. Psychiatry. 65:1998;42-47.
16. Kermode A.G., Thompson A.J., Tofts P.S., et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain. 113:1990;1477-1489.
17. Miller D.H., Barkhof F., Nauta J.J.P. Gadolinium enhancement increased the sensitivity of MRI in detecting disease activity in MS. Brain. 116:1993;1077-1094.
18. Molyneux P.D., Miller D.H., Filippi M., et al. Intra- and inter-observer variation in reporting activity on serial T2-weighted brain MR images in multiple sclerosis. Proceedings of Sixth Scientific Meeting of the International Society for Magnetic Resonance in Medicine. 2:1998;1330.
19. Barkhof F., Filippi M., van Waesberghe J.H., et al. Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis. Neurology. 49:1997;1682-1688.
20. Lee M.A., Smith S., Palace J., Matthews P.M. Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging. Brain. 121:1998;2095-2102.
21. Filippi M., Horsfield M.A., Ader H.J., et al. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann. Neurol. 43:1998;499-506.
22. Rovaris M., Gawne-Cain M.L., Sormani M.P., Miller D.H., Filippi M. The effect of repositioning on brain MRI lesion load assessment in multiple sclerosis: reliability of subjective quality criteria. J. Neurol. 245:1998;273-275.
23. Filippi M., Rovaris M., Sormani M.P., et al. Intraobserver and interobserver variability in measuring changes in lesion volume on serial brain MR images in multiple sclerosis. Am. J. Neuroradiol. 19:1998;685-687.
24. Lycklama à Nijeholt G.J., van Walderveen M.A.A., Castelijns J.A., et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain. 121:1998;687-697.
25. Molyneux P.D., Filippi M., Barkhof F., et al. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis. Ann. Neurol. 43:1998;332-339.
26. Koziol J.A., Wagner S., Adams H.P. Assessing information in T2-weighted MRI scans from secondary progressive MS patients. Neurology. 51:1998;228-233.
27. O'Riordan J.I., Thompson A.J., Kingsley D.P.E., et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A ten-year follow-up. Brain. 121:1998;495-503.
28. Sailer M., O'Riordan J.I., Thompson A.J., et al. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology. 52:1999;599-606.
29. Rovaris M., Filippi M., Falautano M., et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology. 50:1998;1601-1608.
30. Miki Y., Grossman R.I., Udupa J.K., et al. Isolated U-fiber involvement in MS: preliminary observations. Neurology. 50:1998;1301-1306.
31. Arnett P.A., Rao S.M., Bernardin L., Grafman J., Yetkin F.Z., Lobeck L. Relationship between frontal lobe lesions and Wisconsin card sorting test performance in patients with multiple sclerosis. Neurology. 44:1994;420-425.
32. Foong J., Rozewicz L., Quaghebeur G., et al. Executive functions in multiple sclerosis. The role of frontal lobe pathology. Brain. 120:1997;15-26.
33. Filippi M., Iannucci G., Tortorella C., et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology. 52:1999;588-594.
34. Tubridy N., Coles A.J., Molyneux P., et al. Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features. Brain. 121:1998;225-231.
35. Filippi M., Rossi P., Campi A., Colombo B., Pereira C., Comi G. Serial contrast-enhanced MR in patients with multiple sclerosis and varying levels of disability. Am. J. Neuroradiol. 18:1997;1549-1556.
36. Kappos L., Moeri D., Radue E.W., et al. Predictive value of gadolinium-enhanced MRI for relapse rate and changes in disability/impairment in multiple sclerosis: a metaanalysis. Lancet. 353:1999;964-969.
37. Paty D.W., Li D.K.B. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. 2: MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology. 43:1993;662-667.
38. Calabresi P., Stone L.A., Bash C.N., Frank J.A., McFarland H.F. Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI. Neurology. 48:1997;1446-1448.
39. Simon J.H., Jacobs L.D., Campion M., et al. Magnetic resonance studies of intramuscular Interferon beta-1a for relapsing multiple sclerosis. Ann. Neurol. 43:1998;79-87.
40. Randomised double-blind placebo-controlled study of Interferon beta 1a in relapsing-remitting multiple sclerosis. Lancet. 352:1998;1498-1504.
41. Placebo-controlled multicentre randomised trial of Interferon beta 1b in treatment of secondary progressive multiple sclerosis. Lancet. 352:1998;1491-1497.
42. Gasperini C., Pozzilli C., Bastianello S., et al. Effects of steroids on Gd-enhancing lesions before and during recombinant Interferon beta 1a treatment in relapsing-remitting multiple sclerosis. Neurology. 50:1998;403-406.
43. Oliveri R.L., Valentino P., Russo C., et al. Randomized trial comparing two different high doses of methylprednisolone in MS. A clinical and MRI study. Neurology. 50:1998;1833-1836.
44. Sorensen P.S., Wanscher B., Jensen C.V., et al. Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis. Neurology. 50:1998;1273-1281.
45. Mancardi G.L., Sardanelli F., Parodi R.C., et al. Effect of copolymer-1 on serial gadolinium enhanced MRI in relapsing-remitting multiple sclerosis. Neurology. 50:1998;1127-1133.
46. McDonald W.I., Miller D.H., Barnes D. The pathological evolution of multiple sclerosis. Neuropathol. Appl. Neurobiol. 18:1992;319-334.
47. van Walderveen M.A.A., Kamphorst W., Scheltens P., et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology. 50:1998;1282-1288.
48. van Walderveen M.A.A., Barkhof F., Hommes O.R., et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short TR/short T.E. (T1-weighted) spin-echo images. Neurology. 45:1995;1684-1690.
49. Truyen L., van Waesberghe J.H.T.M., van Walderveen M.A.A., et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology. 47:1997;1469-1476.
50. Losseff N.A., Wang L., Lai H.M., et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain. 119:1996;2009-2019.
51. Filippi M., Mastronardo G., Rocca M.A., Pereira C., Comi G. Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis. J. Neurol. Sci. 158:1998;148-153.
52. Filippi M., Rocca M.A., Gasperini C., et al. Interscanner variation in brain MRI lesion load measurements in multiple sclerosis using CSE, RARE and fast-FLAIR. Am. J. Neuroradiol. 20:1999;133-137.
53. Stevenson V.L., Gawne-Cain M., Barker G.J., Thompson A.J., Miller D.H. Imaging of the spinal cord and brain in multiple sclerosis: a comparative study between fast flair and fast spin-echo. J. Neurol. 244:1997;119-124.
54. Silver N.C., Good C.D., Barker G.J., et al. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain. 120:1997;1149-1161.
55. Tubridy N., Ader H.J., Barkhof F., Thompson A.J., Miller D.H. Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups. J. Neurol. Neurosurg. Psychiatry. 64:1998;50-55.
56. Filippi M., Yousry T., Campi A., et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology. 46:1996;379-384.
57. Filippi M., Rovaris M., Capra R., et al. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. Brain. 121:1998;2011-2020.
58. Rovaris M., Mastronardo G., Gasperini C., Prandini F., Yousry T.A., Filippi M. MRI evolution of new MS lesions enhancing after different doses of gadolinium. Acta Neurol. Scand. 98:1998;90-93.
59. Filippi M., Rovaris M., Capra R., et al. Interferon beta treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology. J Neurol Neurosurg Psychiatry. 67:1999;386-389.
60. Hittmair K., Mallek R., Prayer D., Schindler E.G., Kollegger H. Spinal cord lesions in patients with multiple sclerosis: comparison of MR pulse sequences. Am. J. Neuroradiol. 17:1996;1555-1565.
61. Kidd D., Thorpe J.W., Thompson A.J., et al. Spinal cord MRI using multi-array coils and fast spin-echo. II. Findings in multiple sclerosis. Neurology. 43:1993;2632-2637.
62. Lycklama à Nijeholt G.J., Barkhof F., Scheltens P., et al. MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. Am. J. Neuroradiol. 18:1997;1041-1048.
63. Lycklama à Nijeholt G.J., Castelijns J.A., Weerts J., et al. Sagittal MR of multiple sclerosis in the spinal cord: fast versus conventional spin-echo imaging. Am. J. Neuroradiol. 19:1998;355-360.
64. Tartaglino L.M., Friedman D.P., Flanders A.E., Lublin F.D., Knobler R.L., Liem M. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology. 195:1995;725-732.
65. Gass A., Filippi M., Rodegher M.E., Schwartz A., Comi G., Hennerici M.G. Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1-weighted MRI. Neurology. 50:1998;548-550.
66. Thorpe J.W., Kidd D., Moseley I.F., et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology. 46:1996;373-378.
67. Kidd D., Thorpe J.W., Kendall B.E., et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 60:1996;15-19.
68. Trop I., Bourgouin P.M., Lapierre Y., et al. Multiple sclerosis of the spinal cord: diagnosis and follow-up with contrast-enhanced MR and correlation with clinical activity. Am. J. Neuroradiol. 19:1998;1025-1033.
69. Yousry T.A., Fesl G., Walther E., Voltz R., Filippi M. Triple dose of gadolinium-DTPA increases the sensitivity of spinal cord MRI in detecting enhancing lesions in multiple sclerosis. J. Neurol. Sci. 158:1998;221-225.
70. Thorpe J.W., Kidd D., Moseley I.F., et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain. 119:1996;709-714.
71. O'Riordan J.I., Losseff N.A., Phatouros C., et al. Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination. J. Neurol. Neurosurg. Psychiatry. 64:1998;353-357.
72. Filippi M., Yousry T.A., Alkadhi H., Stehling M., Horsfield M.A., Voltz R. Spinal cord MRI in multiple sclerosis using multi-coil arrays: a comparison between fast spin-echo and fast-FLAIR. J. Neurol. Neurosurg. Psychiatry. 61:1996;632-635.
73. Rocca M.A., Mastronardo G., Horsfield M.A., et al. Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis. Am J Neuroradiol. 20:1999;1710-1716.
74. Losseff N.A., Webb S.L., O'Riordan J.I., et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain. 119:1996;701-708.
75. Stevenson V.L., Leary S.M., Losseff N.A., et al. Spinal cord atrophy and disability in MS. A longitudinal study. Neurology. 51:1998;234-238.
76. Dousset V., Grossman R.I., Ramer K.N., et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology. 182:1992;483-491.
77. Dousset V., Brochet B., Vital A., et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. Am. J. Neuroradiol. 16:1995;225-231.
78. Filippi M., Campi A., Dousset V., et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology. 45:1995;478-482.
79. van Buchem M.A., McGowan J.C., Kolson D.L., Polansky M., Grossman R.I. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn. Reson. Med. 36:1996;632-636.
80. Dousset V., Gayou A., Brochet B., Caille J.M. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies. Neurology. 51:1998;1150-1155.
81. Filippi M., Rocca M.A., Horsfield M.A., Comi G. A one year study of new lesions in multiple sclerosis using monthly gadolinium-enhanced MRI. Correlations with changes of T2 and magnetization transfer lesion loads. J. Neurol. Sci. 158:1998;203-208.
82. Filippi M., Rocca M.A., Rizzo G., et al. Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium. Neurology. 50:1998;1289-1293.
83. Lai H.M., Davie C.A., Gass A., et al. Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis. J. Neurol. 244:1997;308-311.
84. van Waesberghe J.H.T.M., van Walderveen M.A.A., Castelijns J.A., et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization MR. Am. J. Neuroradiol. 19:1998;675-683.
85. Gass A., Barker G.J., Kidd D., et al. Correlation of magnetization transfer ratio with disability in multiple sclerosis. Ann. Neurol. 36:1994;62-67.
86. Silver N.C., Lai M., Symms M.R., Barker G.J., McDonald W.I., Miller D.H. Serial magnetization transfer imaging to characterize the early evolution of new MS lesions. Neurology. 51:1998;758-764.
87. Filippi M., Rocca M.A., Martino G., Horsfield M.A., Comi G. Magnetization transfer changes in the normal-appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann. Neurol. 43:1998;809-814.
88. Goodkin D.E., Rooney W.D., Sloan R., et al. A serial study of new MS lesions and the white matter from which they arise. Neurology. 51:1998;1689-1697.
89. Rocca M.A., Mastronardo G., Rodegher M., Comi G., Filippi M. Long term changes of MT-derived measures from patients with relapsing-remitting and secondary-progressive multiple sclerosis. Am. J. Neuroradiol. 20:1999;821-827.
90. van Waesberghe J.H.T.M., van Buchem M.A., Filippi M., et al. MR outcome parameters in multiple sclerosis: comparison of surface-based thresholding segmentation and magnetization transfer ratio histographic analysis in relation to disability. A preliminary note. Am. J. Neuroradiol. 19:1998;675-683.
91. Phillips M.D., Grossman R.I., Miki Y., et al. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. Am. J. Neuroradiol. 19:1998;1055-1060.
92. van Buchem M.A., Grossman R.I., Armstrong C., et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology. 50:1998;1609-1617.
93. Mastronardo G., Iannucci G., Rocca M.A., et al. Correlations between clinical and MRI cerebellar involvement in multiple sclerosis: assessment with T2, T1 and MT histograms. Neurology. 50:(Suppl 4):1998;108.
94. Tortorella C, Viti B, Bozzali M et al. A magnetization transfer histogram study of normal-appearing brain tissue in multiple sclerosis. Neurology 1999 (in press).
95. Filippi M., Tortorella C., Rovaris M., et al. Changes in the normal-appearing brain tissue and cognitive impairment in multiple sclerosis. J. Neurol. 246:(Suppl 1):1999;I/63.
96. Filippi M, Bozzali M, Horsfield MA et al. A conventional and magnetization transfer MRI study of the cervical cord in patients with multiple sclerosis. Neurology 1999 (in press).
97. Filippi M, Rocca MA, Moiola L et al. MRI and MTI changes in the brain and cervical cord from patients with Devic's neuromyelitis optica. Neurology 1999 (in press).
98. Richert N.D., Ostuni J.L., Bash C.G., Duyn J.H., McFarland H.F., Frank J.A. Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with Interferon beta-1b. Am. J. Neuroradiol. 19:1998;1705-1713.
99. Davie C.A., Hawkins C.P., Barker G.J., et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain. 117:1994;49-58.
100. Pike B.G., De Stefano N., Narayanan S., Francis G.S., Antel J.P., Arnold D.L. Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis. Am. J. Neuroradiol. 20:1999;829-837.
101. Davie C.A., Barker G.J., Thompson A.J., Tofts P.S., McDonald W.I., Miller D.H. H-1 magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal-appearing white matter in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 63:1997;736-742.
102. Falini A., Calabrese G., Filippi M., et al. Benign versus secondary progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. Am. J. Neuroradiol. 19:1998;223-229.
103. Davie C.A., Barker G.J., Webb S., et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axonal loss. Brain. 118:1995;1583-1592.
104. De Stefano N., Caramanos Z., Preul M.C., Francis G., Antel J.P., Arnold D.L. In vivo differentiation of astrocytic brain tumors and demyelinating lesions of the type seen in multiple sclerosis using H-1 magnetic resonance spectroscopic imaging. Ann. Neurol. 44:1998;273-278.
105. De Stefano N., Matthews P.M., Fu L.Q., et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain. 121:1998;1469-1477.
106. Fu L., Matthews P.M., De Stefano N., et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain. 121:1998;159-166.
107. Narayana P.A., Doyle T.J., Lai D.J., Wolinsky J.S. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging and quantitative lesion volumetry in multiple sclerosis. Ann. Neurol. 43:1998;56-71.
108. Sarchielli P., Presciutti O., Tarducci R., et al. H-1 MRS in patients with multiple sclerosis undergoing treatment with Interferon beta-1a: results of a preliminary study. J. Neurol. Neurosurg. Psychiatry. 64:1998;204-212.
109. Le Bihan D. Separation of diffusion and perfusion in intravoxel incoherent motion (IVIM) MR imaging. Radiology. 168:1988;497-505.
110. Larsson H.B., Thomsen C., Frederiksen J., Stubgaard M., Henriksen O. In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. Magn. Reson. Imaging. 10:1992;7-12.
111. Christiansen P., Gideon P., Thomsen C., et al. Increased water self-diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis. Acta Neurol. Scand. 87:1993;195-199.
112. Horsfield M.A., Lai M., Webb S.L., et al. Apparent diffusion coefficient in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance. Magn. Reson. Med. 36:1996;393-400.
113. Tievsky A.L., Ptak T., Wu O., et al. Evaluation of MS lesions with full tensor diffusion weighted imaging and anisotropy mapping. Proceedings of the International Society for Magnetic Resonance in Medicine. 1:1997;666.
114. Gass A., Gaa J., Schreiber W., Schwartz A., Hennerici M.G. Echo planar diffusion weighted magnetic resonance imaging in patients with active multiple sclerosis. Proceedings of the International Society for Magnetic Resonance in Medicine. 1:1997;658.
115. Droogan A.G., Clark C.A., Werring D.J., et al. Comparison of multiple sclerosis clinical subgroups using navigated spin-echo diffusion-weighted imaging. Magn. Reson. Imaging. 17:1999;653-661.
116. Werring D.J., Clark C.A., Barker G.J., Thompson A.J., Miller D.H. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology. 52:1999;1626-1632.
117. Clanet M., Berry I., Boulanouar K. Functional imaging in MS. Int. MS J. 4:1997;26-32.
118. Rombouts S.A.R.B., Lazeron R.H.C., Scheltens P., et al. Visual activation patterns in patients with optic neuritis: an fMRI pilot study. Neurology. 50:1998;1896-1899.